Published in Gene Therapy Weekly, September 16th, 1996
The first U.S. Patent covers the p53 GeneKit, which allows users to quickly and inexpensively detect possible mutations in the DNA code of the p53 gene. The second, covers the RB1 GeneKit, which allows users to search for possible mutations in the RB1 gene from a simple blood sample.
Mutations in the p53 gene are found in a wide variety of tumors, including about 70 percent of colorectal cancers, 50 percent of lung...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.